Tag: J&J
J&J begins enrolment in pivotal studies evaluating first-of-its-kind carotid IVL platform
Johnson & Johnson (J&J) announced today the initiation of its SKYWARD investigational device exemption (IDE) clinical programme evaluating the novel Shockwave SkyRunner carotid intravascular lithotripsy...
Johnson and Johnson announces new neurovascular business, Cerenovus
Johnson and Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...
